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Abstract 
Purpose. The increase of epicardial adipose tissue但AT)in le武 atrium(LA) 
predicts the progression of atrial fibrillation (AF) and AF recuηence after 
pulmonary vein catheter ablation (CA). We hypothesized that EAT in right atrium 
(RA) is also associated with the progression of AF and post-CA AF recu汀ence.
Methods. Using 128-slice multidetector computed tomography, EAT volume and 
ぐぽrialvolume were measured 3-di附
〈ト
initialy proven AF ( 42 paroxysmal patients and 26 persistent pati巴nts;the m巴an 
age, 65士 1years; 42.6% female) with successful CA and 21 volunt巴erswith sinus 
rhythm (63士13years; 52.3% female). 
Results. In both atria, EAT and atrial volum巴 werethe greatest in patients with 
persistent AF, followed in order by those with paroxysmal AF and healthy 
volunteers (pく0.001).The increases of EAT and atrial volume predicted the 
persistent AF in both atria (pく0.001).Fifteen patients had AF recurrence (22.1%) 
during the 2・yearperiod after CA. The increases of EAT in both atria were the 
independent predictors for AF recurrence, and RA EATと6.2mL was an 
independent predictor with HR of 5.47 [95%CI 1.2 to 24.3; p=0.03]. The 
combination of EAT and atrial volume in both atria was a more powerful 





1.7 to 13.7; p=0.003] (sensitivity, 60% in 9of15 patients, and specificity, 81.1% in 
43 of 53 patients, p=0.003). 
Conclusion. RA EAT was associated with the progression of AF and post・CAAF
recurrenc巴．
Key words: Atrial Fibrillation; Adipose Tissue; Right Atrium; epicardium; catheter 




Several studies demonstrate that the volume of epicardial adipos巴 tissue
(EAT) is associated with the progression of atrial fibrillation (AF) and AF 
re cu汀enc巴 aftercatheter ablation (CA), and these close relationships have been 
reported to result from the inflammation leading to remodeling of the left atrium 
(LA) [1・3].A recent study indicates that the distribution of EAT in LA isimportant 
ぐ fora trigger of AF [4]. On the other hand, the right atrial （貼） remodeling has also 
be巴nreported in patients with AF, and the fibrosis with remodeling of not only LA 
but also RA plays an important role in AF recu町ence[ 5]because AF is sometimes 
initiat巴dby the non-pulmonary vein (PV）巴ctopicbeats which arise企omRA side 
other than PV [6,7]. Atrial size and EAT volume can be quantified from 
multidetector computed tomography (MDCT) imaging [8,9]. We hypothesized that 
ι 
RA EAT volume measured using MDCT is associated with the progression of AF 
and AF recurrence after CA. 
2. Materials and Methods 
Study Population 
We recruited consecutively patients who had a history of palpitations and 
were initialy diagnosed with AF at Showa University Hospital, Tokyo, Japan. A 
diagnosis of AF and a discriminate of AF between paroxysmal and persistent were 
considered on the AHA/ACC圧虫Sguid巴line[10]. Before the present 山 dy,left 
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ventricular ejection企action(L VEF) and LA dimension were m巴asuredwith 
2・dimensionalechocardiography. Diseas巴sthat could cause pathological fibrosis 
and adipose tissue replacement in the atrium were excluded. Patients who had 
ischemic heart disease, valvular heart disease, cardiomyopathy, congenital heart 
disease, thyroid disease, chronic kidney disease, collagen disease, hematologic 
disease, inflammatory disease, or malignancy were excluded from this study. 
( Patients were also excluded if they had pre-excitation syndrome, atriovent山 ular
tachycardia or verr仕iculartachya町hythmia,or an implanted pacemaker before the 
start of the study. After application of th巴 exclusioncriteria, 42 patients with 
paroxysmal AF and 26 patients with persistent AF (mean age, 65土1years; 42.6% 
female) w巴rerecruited for this study. Further, for those who did not meet the 
exclusion criteria, 21 volunteers who had normal sinus rhythm and no history of AF 
were recruited as the control group (age, 63土13years; 52.3% female). Before the 
ι 
procedure, 128・sliceMDCT was performed systematically. All patients provided 
written informed consent before the study, and the protocol was approved by the 
institutional review board. This research was approved by the Ethics committee on 
human research of Showa University (Authorization number; 2592). 
Scan Protocol and Acquisition ofMDCT Data 
Within one week before CA, al patients underwent scanning with a 
128-slice single-source MDCT system (SOMATOM Definition AS+ Siemens 
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Medical Solutions, Forchheim, Germany) when they had less variated rhythm and 
were not exp巴riencingtachyarrhythmia （く75bpm). The procedure was conducted 
without contrast media to measure atrial volume and the EAT volume. Each scan 
was performed in a single breath hold in the craniocaudal direction, from the aortic 
arch to the diaphragm. The scan was gated to the cardiac cycl巴 throughECG 
synchronization with the following parameters: collimation, 2× 64× 0.6 mm; 
ぐ rotationtime, 300 ms; tube叫 age,120 kV; efi削 ive旬becurr捌， 800mA; and 
pitch, 0.3. Raw CT data were reconstruct巴dwith algorithms that were optimized for 
retrospectively ECG-gated segmental reconstruction with slice thickness of 0.6 mm 
and increment of 0.3 mm. ECG司gateddata sets were reconstruct巴dat the point of 
the cardiac cycle that corresponded to atrial end diastole [9]. 
ι 
Measurement of Atrial Volume and EAT Volume With MDCT 
Reconstructed CT image data were transferred to a workstation for 
post-processing (Synapse Vincent, Fujifilm, Tokyo, Japan). EAT volume and atrial 
volume were measured 3・dimensionallyin al patients with norトcontrast-enhanced
images (Figure 1 ). The area of EAT was calculated by tracing a region of interest 
(ROI), which included each atrium with EAT. The ROI was manually placed 
outside the line of the visceral pericardium on a cross-sectional axial image. The 
area outside the traced pericardium was excluded [11 ]. Areas of EAT surrounding 
the LA and RA were separately assessed by tracing ROI containing atrium and EAT. 
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EAT volume was detected by assessing Hounsfield units (HU) of -50 to -200, and 
atrial volume was detected by assigning HU of more than 0.、＇olumeswere 
reconstructed from contiguous slices of axial images企omthe left main coronary 
artery to the apex and were summed automatically [12]. The measurements were 
performed offlin巴 by2 blinded observers. To determine the r巴producibilityof 
MDCT, 2 investigators rep巴atedthe EAT measurements at 2 different time points 
ぐ for30 randomly selected participants. The ir附 ob即 verand intraobserv巴r
correlations for RA EAT were r=0.951 and r=0.953, respectively (pく0.001),and 
r=0.96 and r=0.944 respectively for LA EAT (pく0.001).
t』
Pulmonary Vein CA 
The NAVX-Ensite system (St. Jude Medical, Inc., St Paul，乱⑪-T,USA) was 
used for nonfluoroscopic 3-dimensional catheter orientation and CT image 
integration. Af王erone transseptal puncture and two long-sheath insertions in the LA, 
radio frequency ablation and ring catheters were positioned, and the CA procedure 
was performed with a steerable sheath (Agilis, St. Jude Medical, IncふThe
pulmonary vein ablation procedure was essentially ipsilateral pulmonary vein 
isolation. Line ablations (mitral isthmus, roof, and bottom lines in the LA) were 
added in patients with persistent AF. An irrigated catheter was us巴dwith an initial 
maximum power of 25-35 W, depending on each physician and by the dragging 
method used with a steerable sheath. Electrical isolation of al pulmonary veins was 
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attempted with bidirectional conduction block in al patients. After the procedure, 
successful CA was confirmed by PV stimulation. 
Follow-up After Pulmonary Vein CA 
After CA, al patients had prospectiv巴follow-upat least once every 4 weeks 
without antiarrhythmic drugs. Recurrence of AF was assessed企om1 month to 2 
years, and recuπence was defined as documented AF by 12-lead ECG and at least 
( one 24四hourHolter monitoring to obs即日制iacrhy伽.In addition，倒的al
loop recording was performed for as long as possible. Further, 12・leadECG and 
Holter monitoring were performed during follow-up for patients who reported an 
i町egularheart beat or palpitations. 
ι 
Statistical Analysis 
Comparisons between groups wer巴 performedwith 1-way analysis of 
variance, unpaired Student’s t test, Fisher’s exact test, or a Bonferroni test for 
continuous variables and the chi-square test for categoric variables. Associations 
between the predictors and AF recu町encewere formally tested by construction of a 
Cox proportional hazards model with regression analysis. The tolerance of variance 
inflation factor (VIF) was calculated to evaluate multicollinearity in the multiple 
regression analysis model. For descriptive purposes, receiver operator characteristic 
(ROC) analysis was performed to defin巴 thresholdsfor those factors, and the 




method. The cutoff values were defined by minimizing the expression of (1-
sensitivity/+ (1 sp巴cificity)2on AUC. Statistical analysis was performed with 
SPSS for Windows, version 20 (SPSS Inc., IBM, Chicago, IL). A probability value 
of <0.05 was considered significant. 
3. Results 
Patient Characteristics 
There was no significant difference in age, gender, body mass index (BMI), 
and coronary risk factors between the patients with persistent AF and paroxysmal 
AF, and control group. Low-density lipopr悦 eincholesterol (LDL) was similar 
between them (p=O. l ), but high-sensitivity C-reactive protein (hsCRP) was higher 
in patients with persistent AF than those with paroxysmal AF or the control group 
(p=0.003) (Table 1 ). The diameter of the LA on echocardiography was greater in 
patients with persistent AF than in those with paroxysmal AF ( 46士5.3mm versus 
40.7土 5.3mm, p=0.001), but LVEF W巴resimilar in the difference of AF type (61.6 
士9.8%versus 58. 7土 8.4%).
EAT Volume for Progression of AF 
In both atria, EAT and atrial volume were greatest in patients with persistent 
AF, followed in order by patients with paroxysmal AF and the control group with 
sinus rhythm (pく0.001)(Figure 2). In patients with AF, the persistent AF was 




(0.67, p=0.02), and LA volume (0.8, pく0.001),and RA EAT volume was correlated 
with LA EAT volume (r=0.69), RA and LA volume (r=0.32 and r=0.42), and B阻
(r=0.47) in patients with AF (pく0.001in each). 
Continuous Factors for Predicting AF Recurrence 
All patients had follow-up for 2 years a食erCA, and 15 patients had AF 
recurrence (22 .1 % ).Patients with persistent AF and paroxysmal AF had a similar 
number of recurrences of AF (30.8% in 8 of 26 patients versus 16. 7% in 7 of 42 
patients, p=0.23). 
The low-density lipoprotein (LDL) cholesterol level was higher in patients 
with AF recu汀encethan in those without AF recu町ence(p=0.04) (Table 2). The 
patients with the statin treぽmentwere not likely to AF recurrence (p=0.05). AF 
re cu町encewas associated with RA EAT volume (p=0.001), LA EAT volume 
(p=0.02), LA volume (p=0.006) on MDCT and as well as with dimension of the LA 
on echocardiography (p=0.007). When the VIFs such as atrial volume in both RA 
and LA were excluded from this model in multivariable analysis, the predictive 
factors for AF recu汀巴ncewere analyz巴dincluding each of RA EAT or LA EAT. 
After adjustment for potential confounding variables such as ag巴， BMI,LDL, and 
hsCRP, the increases of RA EAT and LA EAT were the independent predictive 
factors (p=0.001 and p=0.02) (Table 3). 
Categoric Factors and AF Recurrence 
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RA EAT volume was similar in the AUC for predicting AF recu汀encetoLA 
EAT (0.7 versus 0.69, p=0.83), RA volume (versus 0.63, p=0.41), and LA volume 
(versus 0.73, p=0.69), but the AUC was greater with LA volume than with RA 
volume (p=0.04) (Figure 3). The larger RA EAT volume >6.2 mL was predictive of 
AF recuηence (Table 4 ). LA EAT volume >6.8 mL and LA volume > 117 mL were 
also the significant predictive factors of AF recurrence, but RA volume >88 mL 
ぐ wasjust outside the reach (Figure 4). LDL 1巴vel>125 mg/dL, hsCRP level >0.067 
mg/dL, and N-terminal brain natriuretic peptide (BNP) level >75 pg/mL were also 
the significant predictive mark巴rsof AF recurrence. The VIFs such as atrial volume 
in both RA and LA were excluded from this model in multivariable analysis. 
ι 
LA Volume, RA Volume, LA EAT Volume, and RA EAT Volume for Predicting 
AF Recurrence 
羽市enthe predictive factors for AF recu汀巴ncewere analyzed including RA EAT, 
after adjustment for potential confounding variables such as older age, higher BMI, 
a history of persistent AF, higher LDL level, high巴rhsCRP level, and higher BNP 
level, RA EAT >6.2 mL was an independent predictive factor for AF recuηence 
with HR of 5.47 [95%CI 1.2 to 24.3; p=0.03]. When the predictive factors for AF 
recu町巴ncewere analyzed including LA EAT, LA EAT >6.8 mL was not an 
independent predictive factor, but higher LDL level > 125 mg/dL predict巴dthe AF 




The combined estimate of 4 factors as LA volume, RA volume, LA EAT volume, 
and RA EAT volume provided incremental and additive prognostic power of AF 
re cu町encecompared with LA volume alone (Table 5). After adjustment for 
potential confounding variables, the combination of those 4 factors had a most 
powerful independent prognostic pow巴r,with HR of 4.8 [95% CI, 1.7 to 13.7; 
p=0.003]. 
4. Discussion 
RA EAT volume was associated with the progression of AF and post-CA AF 
recurrence. 
Atrial EAT and progression of AF 
Al Chekakie et al. [1] compared whole heart EAT volume among patients 
with persistent AF, paroxysmal AF, and sinus rhythm, and found a close 
relationship between EAT volume and progression of AF. They showed that whole 
heart EAT volume is corr巴latedwith LA volume. Nagashima et al.[4] also report巴d
that patients with persist巴ntAF, in comparison with those with paroxysmal AF, had 
increased total heart EAT and LA EAT volumes, and serum high”sensitivity CRP 
and interleukin-6 levels as elevated biomarkers of inflammation and collagen 
turnover. We found that EAT volume in not only LA but also RA isassociated with 
the progression to persistent AF. 
Atrial EAT and Post-CA AF recurrence 
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The previous studies [9,13,14] showed that myocardial damag巴， anatrial 
enlargement, and a symmetric change in electric remodeling were similar in 
magnitude between the LA and the RA in AF patients. Although there are some 
distinct differences in anatomy between the atria [15], atrial dyssynchrony with AF 
leads to structural remodeling in both atria simultaneously [16], and systemic 
inflammation and endothelial dysfunction may target both atria equally [ 17]. 
ぐ Local fa町 infiltrationc加問 thefibrosis of 叫acentmyocardium, which 
ι 
leads to AF recu町ence[18]. The close relationship betwe巴nAF focus and 
distribution of EAT in LA was recently reported using LA high-dominant-frequency 
(DF) during electrophysiological study [4]. The patients with AF concomitant with 
sick sinus s戸idromeare at higher risk for AF recu汀ence[19], and the specific 
characteristics of ionic remodeling in sinoatrial node tissue within the RA may 
affect the trigger巴dactivity mechanism and the pr巴：valenceof non-PV foci other 
than LA [20]. Howev巴r,Hase be et al. [21] demons仕atedthat RA EAT volume was 
not larger in 8 patients with AF characterized by RA ectopic initiation and 
right-to田 leftDF gradients than that in 32 patients characterized by initiation of LA. 
These results indicate that the pathophysiology of AF is not simple, and the 
re cu汀enceof AF following ablation is multifactorial and complex. However, w巴
found that RA EAT is important for the recu汀enceof AF in the present study. 
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Other Factors for Predicting the progression of AF and Post-CA AF 
recurrence 
EAT is associated with clinical characteristics of the metabolic syndrome 
including waist circumfi巴renceand LDL-cholesterol levels [22]. Soucek, et al. [23] 
showed in post-CA AF patients that atorvastatin exhibited a significant reduction in 
EAT volume, CRP level, and LDL cholesterol after 3 months of therapy, while BMI, 
ぐ HDL-cholesteroland triglycerides did not伽 ngeappreciably. Similar!ぁ LDL
cholesterol was associated with AF recurrence (p=0.04), and the use of statin had a 
tendency of no recu町enceof AF (p=0.05) in the present study. Lin et al.[24] also 
reported that CRP level and LA diameter had an ind巴pendentprognostic value in 
predicting AF recuηence. In the present study, hsCRP level was higher in patients 
with persistent AF than in those with paroxysmal AF, and the higher hsCRP level 
(>0.067 mg/dL) predict巴dthe AF recu町ence.However, a食eradjustment for those 
ι 
factors, EAT >6.2 mL was an independent predictive factor for AF recu町ence.
Diagnostic Accura句rof RA EAT for Predicting AF Recurrence 
Sanghai et al. [25] showed that LA EAT >0.95 cm2/body surface area (m2) 
on 128-slic巴 MDCTwas a sens抗ivityof 45% and a specificity of 25.5% for 
predicting the AF recu町enceover 12 months follow-up in patients with mixed AF. 
In a population of patients with mixed AF at follow-up of a median of 10.2 months, 




predictiv巴ofAF recurrence, with sensitivity of 60.0% and specificity of 96.0%. In 
the present s旬dy,we found that RA EAT volum巴＞6.2mL was predictive of AF 
re cu汀encein a population of patients with mixed AF at approximately 2 years of 
follow開 up,with sensitivity of 86.7% and specificity of 50.9%. Further, the 
combination of EAT in both RA and LA was a powerful prognostic factor of AF 
re cu町encewith HR of 4.4 [95%CI 1.4 to 13.8; p=0.01], and the combination of 
EAT and atrial volume in both atria was more predictive of AF recu町encethan 
either factor alone (sensitivity of 60% and specificity of 81.1 %). 
Study Limitations 
In the present study, the small sample size was a m付orlimitation, and a 
study with a large cohort should be conducted to verify these findings. The 
different technical protocols or procedures of CA may result in dif巴rentcutoff 
values of atrial volume and atrial EAT volume in predicting the AF recurrence. Our 
values of EAT were smaller than those in Sanghai et al. [25] or Nagashima et al. [2]. 
EAT volume is different by the machine accuracy ofMDCT, the measured method, 
the measured extent around the heart, and the time course of persistent of AF [26]. 
How巴ver,EAT volum巴inthe present study was measured similarly to a report of 
Shin et al. [ 12], and our values were similar to their valu巴s(the mean旬旬lheart 





RA EAT volume was associated with the progression of AF and post-CA AF 
recurrence. Our findings may have important implications for consid巴ringthe 
condition of RA in patients with AF undergoing PV isolation. 
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Figure 1. Quantitative measurement of EAT and atrial volume. 
(A) The area related to the LA was traced in green, (B); the area related to the LA 
EAT (yellow-green) was detected by assigning Hounsfield units (HU) of -50 to 
-200, (C); the area with the LA (green) was detected by assessing HU of more than 
0. (D); the area related to the RA EAT (green) was detected similar to the LA 
volume measurement, (E); the area related to the RA (green) was detected similar 
to the RA volume measurement. 
Figure 2. Comparison of EAT and atrial volume. 
EAT and atrial volume w巴regreatest in patients with persistent AF, followed in 
order by patients with paroxysmal AF and the control group with sinus rh戸hm.
Figure 3. ROC curves of EAT and atrial volume for diagnosing AF recuηence after 
catheter ablation. 
RA EAT was similar in the AUC for predicting AF recurrence to LA EAT, RA 
volume, and LA volume, but the AUC was greater with LA volume than with RA 
volume. 
Figure 4. 
Kaplan開 Meiersurvival curves of EAT and atrial volume in each atria for predicting 




The increases of EAT in both atrial and LA volume W巴rethe significant predictive 
markers of AF recurrence, but a larger RA volume was just outside the reach. 
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(n = 26) 
Paroxysmal AF 
(n = 42) 
Control 
(n = 21) 
P-value 
(ANOVA) 
Age (years) 64 ± 10 66 ± 11 63 ± 5 0.55 
Female, n (%) 7 (26.9%) 22 (52.4%) 11 (52.4%) 0.09 
Body mass index (kg/m²) 25.2 ± 2.9 23.7 ± 4.5 23.3 ± 1.7 0.19 
Diabetes mellitus, n (%) 4 (15.4%) 4 (9.5%) 4 (19.0%) 0.57 
Hypertension, n (%) 15 (57.7%) 24 (57.1%) 12 (57.1%) 1.00 
Dyslipidemia, n (%) 9 (34.6%) 20 (47.6%) 8 (38.1%) 0.53 
History of stroke, n (%) 1 (3.8%) 3 (7.1%) 0 0.32 
Smoker, n (%) 14 (53.8%) 15 (35.7%) 8 (38.1%) 0.32 
Triglyceride (mg/dL) 172 ± 136 145 ± 92 165 ± 144 0.64 
High-density lipoprotein-cholesterol (mg/dL) 50 ± 13 56 ± 15 60 ± 15 0.07 
Low-density lipoprotein-cholesterol (mg/dL) 124 ± 29 120 ± 31 106 ± 26 0.10 
High-sensitivity C-reactive protein (mg/dL) 0.15 ± 0.12**†† 0.08 ± 0.10 0.07 ± 0.04 0.003 
N-terminal brain natriuretic peptide (pg/mL) 88 ± 33* 64 ± 26 16 ± 15 0.03 
Creatinine (mg/dL) 0.9 ± 0.2* 0.8 ± 0.2 0.7 ± 0.2 0.02 
Medications before catheter ablation, n (%)     
Use of ARB 12 (46.2%) 12 (28.6%) 7 (33.3%) 0.37 
Use of ß-blocker 9 (34.6%) 24 (57.1%) 2 (9.5%) 0.001 
Use of calcium channel antagonista 15 (57.7%) 18 (42.9%) 6 (28.6%) 0.14 
Use of sodium channel blocker 3 (11.5%) 3 (7.1%) 0 0.41 
Use of statinb 5 (19.2%) 15 (35.7%) 7 (33.3%) 0.37 
Values are mean ± standard deviation, unless otherwise indicated. *P < 0.05, **P < 0.01 vs. control; ††P < 0.01 vs. 
paroxysmal AF group. aCalcium channel antagonist includes bepridil; bStatin is hydroxymethylglutaryl-CoA reductase 
inhibitor. AF, atrial fibrillation; ANOVA, analysis of variance; ARB, angiotensin converting enzyme inhibitor or receptor 
blocker. 





(n = 15) 
No recurrence 
of AF 
(n = 53) 
P-value 
 
Age (years) 67 ± 11 65 ± 11 0.39 
Female, n (%) 7 (46.7%) 8 (41.5%) 0.77 
Body mass index (kg/m²) 25 ± 2.6 24.1 ± 4.4 0.45 
Diabetes mellitus, n (%) 2 (13.3%) 6 (11.3%) 0.85 
Hypertension, n (%) 6 (40.0%) 33 (62.0%) 0.15 
Dyslipidemia, n (%) 3 (20.0%) 26 (49.0%) 0.07 
History of stroke, n (%) 2 (13.3%) 2 (3.8%) 0.21 
Smoker, n (%) 7 (46.7%) 22 (41.5%) 0.77 
Triglyceride (mg/dL) 218 ± 31 202 ± 36 0.41 
High-density lipoprotein-cholesterol (mg/dL) 50 ± 13 54 ± 15 0.37 
Low-density lipoprotein-cholesterol (mg/dL) 135 ± 28 117 ± 30 0.04 
High-sensitivity C-reactive protein (mg/dL) 0.12 ± 0.09 0.10 ± 0.12 0.70 
N-terminal brain natriuretic peptide (pg/mL) 112 ± 101 62 ± 89 0.07 
Creatinine (mg/dL) 0.8 ± 0.2 0.8 ± 0.2 1.00 
Echocardiographic findings    
Left ventricular ejection fraction (%) 62 ± 8 60 ± 10 0.39 
Left atrial diameter (mm) 47 ± 7 42 ± 6 0.005 
Medications before catheter ablation, n (%)    
Use of ARB 4 (26.7%) 20 (37.7%) 0.55 
Use of ß-blocker 6 (40.0%) 27 (50.9%) 0.56 
Use of calcium channel antagonista 4 (26.7%) 20 (37.7%) 0.55 
Use of sodium channel blocker 2 (13.3%) 4 (7.5%) 0.61 
Use of statinb 1 (6.7%) 19 (35.8%) 0.05 
Values are mean ± standard deviation, unless otherwise indicated. aCalcium channel 
antagonist includes bepridil; bStatin is hydroxymethylglutaryl-CoA reductase 





Table 3. Continuous variable risk factors for recurrence of atrial fibrillation after pulmonary vein catheter ablation 
Variable Regression 
Analysis 









Increase in age (years) 0.018 1.02 (1.00-1.07) 0.46 0.50 0.83 
Increase in body mass index (kg/m2) 0.059 1.06 (0.90-1.20) 0.88 0.35 0.58 
Increase in low-density lipoprotein-cholesterol (mg/dL) 0.015 1.06 (1.00-1.03) 3.53 0.06 0.95 
Increase in high-sensitivity C-reactive protein (mg/dL) 0.942 2.57 (0.05-143.80) 0.21 0.65 0.77 
Increase in N-terminal brain natriuretic peptide (pg/mL) 0.003 1.003 (1.00-1.01) 2.45 0.12 0.63 
Increase in LA EAT volume (mL) by MDCT 0.142 1.15 (1.02-1.31) 5.08 0.02 0.45 
Increase in LA volume (mL) by MDCT 0.018 1.02 (1.01-1.03) 7.43 0.006 0.23 
Increase in RA EAT volume (mL) by MDCT 0.134 1.14 (1.06-1.24) 10.70 0.001 0.45 
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VIF, variance inflation factor; CI, confidence interval; LA, left atrium; EAT, epicardial adipose tissue; MDCT, multidetector 
computed tomography; RA, right atrium. 
  
Increase in RA volume (mL) by MDCT 0.015 1.02 (1.00-1.04) 2.64 0.10 0.31 
Increase in left ventricular ejection fraction (%) 0.025 1.03 (0.97-1.09) 0.71 0.40 0.82 
Increase in LA dimension (mm) by echocardiography 0.110 1.12 (1.03-1.22) 7.29 0.007 0.49 
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Age > 68 years 1.12 3.1 (1.0-9.0) 4.18 0.04 
Body mass index ≥ 25 kg/m2 0.96 2.6 (0.9-7.4) 3.32 0.07 
Persistent AF 0.71 2.0 (0.7-5.6) 1.88 0.17 
Low-density lipoprotein-cholesterol ≥ 125 mg/dL 1.27 3.6 (1.1-11.2) 4.70 0.03 
High-sensitivity CRP ≥ 0.067 mg/dL 1.20 3.3 (1.1-10.5) 4.24 0.04 
N-terminal brain natriuretic peptide ≥ 75 pg/mL 1.14 3.1 (1.1-8.6) 4.82 0.03 
Echocardiographic findings     
LA dimension ≥ 48 mm 1.37 3.9 (1.4-10.9) 6.99 0.008 
Left ventricular ejection fraction < 63% -0.39 0.7 (0.2-2.0) 0.51 0.50 
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CI, confidence interval; AF, atrial fibrillation; CRP, C-reactive protein; LA, left atrium; MDCT, multidetector computed 









MDCT findings     
LA volume ≥ 117 mL 1.90 6.7 (1.5-26.7) 6.22 0.01 
RA volume ≥ 88 mL 1.10 3.0 (0.8-10.7) 2.91 0.09 
LA EAT volume ≥ 6.8 mL 1.19 3.3 (1.0-10.3) 4.13 0.04 
RA EAT volume ≥ 6.2 mL 1.69 5.4 (1.2-24.0) 4.93 0.03 
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Table 5. Combination of EAT volumes and right and left atrial volumes for atrial fibrillation recurrence after 
pulmonary vein catheter ablation 












Combined estimate of atrial and EAT volumes     
LA volume ≥ 117 mL and RA volume ≥ 88 mL 1.77 5.9 (1.7 - 20.9) 7.48 0.006 
LA EAT volume ≥ 6.8 mL and RA EAT volume ≥ 6.2 mL 1.48 4.4 (1.4 - 13.8) 6.41 0.01 
LA volume ≥ 117 mL and LA EAT volume ≥ 6.8 mL 1.44 4.2 (1.4 - 12.4) 6.87 0.009 
RA volume ≥ 88 mL and RA EAT volume ≥ 6.2 mL 1.42 4.2 (1.3 - 13.1) 5.92 0.02 
LA volume ≥ 117 mL, RA volume ≥ 88 mL, LA EAT 
volume ≥ 6.8 mL, and RA EAT volume ≥ 6.2 mL 
1.58 4.8 (1.7 - 13.7) 8.85 0.003 
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Figure 1. 
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Figure 4. 
 
 
 
